Nucryst Pharmaceuticals Corporation
101 College Road East
Princeton,
NJ 08540
United States - Map
Phone: 609-228-8210
Fax: 609-228-8220
Web Site: http://www.nucryst.com
| NUCRYST Pharmaceuticals Corp. engages in the manufacture, research, development, and commercialization of medical products in Canada and the United States. The company develops medical products based on its noble metal nanocrystalline technology, which fight infection and inflammation. It produces nanocrystalline silver as a coating for wound care products under the SILCRYST name, and as a powder, known as NPI 32101, for use in medical devices and as an active pharmaceutical ingredient. The company licenses Smith & Nephew plc the exclusive right to market, distribute, and sell products with companys SILCRYST technology for use on non-minor skin wounds and burns on humans. NUCRYST Pharmaceuticals markets its products to hospitals, clinics, burn centers, doctors, offices, home healthcare agencies, and nursing homes for various wound types. The company was founded in 1997 and is headquartered in Princeton, New Jersey. NUCRYST Pharmaceuticals Corp. is a subsidiary of The Westaim Corporation. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. David B. Holtz , 42
Interim Chief Exec. Officer, Interim Pres, Chief Financial Officer and Member of Grant Committee |
$
204.00K | N/A | Mr. David C. McDowell , 54
VP of Operations |
N/A
| N/A | Mr. Barry M. Heck , 47
Non-Independent Director, Member of Special Committee, Chief Exec. officer of Westaim, Pres of Westaim of Westaim |
$
84.00K | N/A | Ms. Carol L. Amelio , 47
VP, Corp. Sec., Gen. Counsel and Member of Grant Committee |
N/A
| N/A | Mr. Edward Gaj Jr., R.Ph,
Consultant |
$
240.00K | N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.01% Nasdaq 0.00%
Profile
